Can Autoimmune NSIP Occur With Negative Blood Tests?

Yes. It is entirely possible to have autoimmune-associated non-specific interstitial pneumonia (NSIP) even if your initial autoimmune blood tests are negative. While a positive blood test can strongly support an autoimmune diagnosis, a negative test lowers the likelihood but does not permanently rule it out ^[1][2].

Autoimmune conditions are complex, and lung involvement can sometimes be the very first—or only—sign of the disease ^[3]. In these situations, doctors use a combination of your physical symptoms, imaging, and careful exclusion of other causes to look for clues of autoimmunity, rather than relying on blood tests alone.

What the Terms Mean

To understand how doctors diagnose these conditions, it helps to know a few key terms:

• Connective Tissue Disease (CTD): Systemic autoimmune diseases like rheumatoid arthritis, lupus, or scleroderma. When these cause lung disease, it is called CTD-associated ILD.
• IPAF (Interstitial Pneumonia with Autoimmune Features): A working research classification for lung disease that has strong autoimmune clues (like certain symptoms or CT patterns) but doesn’t meet the strict criteria for a defined CTD ^[1][4].
• Idiopathic NSIP: NSIP where no underlying cause—such as autoimmunity, medication side effects, or environmental exposures—can be found.

Why Negative Blood Tests Aren’t the Final Answer

When diagnosing interstitial lung diseases like NSIP, doctors typically run a broad panel of autoimmune blood tests (your serology). These look for specific autoantibodies—proteins created by your immune system that mistakenly target your own tissues. Common tests include the Antinuclear Antibody (ANA), Rheumatoid Factor (RF), anti-CCP, and Extractable Nuclear Antigens (ENA).

However, these tests have limitations:

• Antibodies might not be present yet: Autoimmune diseases evolve over time. Lung inflammation (like NSIP) can appear months or even years before autoantibodies show up in the blood ^[3][5].
• Tests don’t catch everything: A negative test does not mean a disease is completely absent. For example, one study found that roughly 19% of patients with rheumatoid arthritis-associated lung disease had negative anti-CCP tests ^[6]. Similarly, tests for Sjögren’s syndrome (anti-SSA and anti-SSB) can be negative in some patients who are later diagnosed with the condition through other objective tests ^[7].
• Testing methods vary: Different labs use different thresholds for what counts as a “positive” ANA test, meaning results can vary depending on where and how the test is interpreted ^[8][9].

Because of these nuances, a negative autoimmune panel is just one piece of the puzzle. Before labeling NSIP as “idiopathic,” your care team must also rule out other potential causes, such as medication side effects, occupational hazards (like inhaling certain dusts), or past infections ^[1][2].

How “Seronegative” Autoimmune NSIP is Identified

If your blood tests are negative, doctors look at other clues using the IPAF framework ^[4][1]. To be classified with IPAF, a patient must have an interstitial pneumonia, have other causes (like exposures) ruled out, not meet criteria for a defined CTD, and show clues from at least two of the following three domains ^[1][2]:

1. Clinical domain: Physical symptoms outside the lungs, such as Raynaud’s phenomenon (fingers turning white, then blue, then red in the cold), puffy fingers, unexplained rashes, inflammatory joint pain, or abnormal blood vessels at the base of the fingernails ^[10][11].
2. Serologic domain: Positive autoimmune blood tests.
3. Morphologic domain: Specific patterns seen on high-resolution CT (HRCT) scans or lung biopsies. The NSIP pattern itself is heavily associated with autoimmune disease, though it does not prove an autoimmune cause on its own ^[1][12].

Because you only need clues from two of these three domains, a patient can have a completely negative blood panel (missing the serologic domain) but still be classified as having an autoimmune-featured lung disease based on their physical symptoms and imaging ^[1][2].

The Role of a Multidisciplinary Team

Because these diagnoses are challenging, your case should be reviewed by a multidisciplinary team—typically including a pulmonologist, a rheumatologist, an expert radiologist, and sometimes a pathologist ^[13][14].

A referral to a rheumatologist adds complementary expertise. They are specifically trained to look for subtle physical signs of autoimmunity and can determine if specialized testing is needed ^[13]. For instance, if you have dry eyes or muscle weakness (myositis—inflammation of the muscles), they might suggest targeted eye tests, advanced myositis antibody panels, or minor salivary gland biopsies ^[7][15]. However, these advanced tests and biopsies carry limitations and risks, and are individualized decisions rather than routine steps for everyone with a negative basic panel. Similarly, while a lung biopsy can help characterize the disease, it is an invasive procedure that the team will only recommend if the results will change your treatment plan ^[1].

Finally, ongoing monitoring is essential. In one study tracking patients diagnosed with IPAF, roughly 26% went on to develop a defined connective tissue disease over a six-year period ^[3]. Follow-up doesn’t mean constant repeat blood tests; it involves clinical review of your symptoms and monitoring your lung function and oxygen levels.